Top Story

Chemo Buddies provide comfort, hope to patients with cancer

October 16, 2018
FDA News

FDA approves Talzenna for BRCA-mutated, HER2-negative breast cancer

October 16, 2018
The FDA approved talazoparib — a poly (ADP-ribose) polymerase inhibitor — for the treatment of patients with deleterious or suspected deleterious germline…
FDA News

FDA grants Lynparza orphan drug designation for pancreatic cancer

October 16, 2018
The FDA granted orphan drug designation to olaparib for the treatment of patients with pancreatic cancer, according to the agent’s manufacturer.
In the Journals Plus

Routine genomic screening could help identify otherwise undetected cancer risk

October 16, 2018
Most carriers of genetic mutations known to increase the risk for breast, ovarian, prostate and pancreatic cancers appeared unaware of their mutation carrier status…
Orthopedics Today Grand Rounds

A 63-year-old woman with acute thigh pain in the setting of subacute back, thigh pain

Orthopedics Today, October 2018
Michael C. Ciccotti, MD; A. Scot Brown, MD
A 63-year-old woman developed persistent, insidious, atraumatic low back and right posterior thigh pain. She was seen by her primary care physician and, in the absence…
More Headlines »

Ace the Case: A 72-Year-Old Man With Fatigue, Weight Loss, and Lymphocytosis

There is no commercial support for this activity.

This educational activity will review the diagnosis and management of a 72-year-old man with complaints of increasing…
More »
Meeting News

Technology outpaces medical law, precautions should be taken

August 13, 2018
More »
Resource Centers


Decisions, Decisions: Differentiating Checkpoint Inhibitors for Bladder Cancer

This activity is supported by an educational grant from AstraZeneca Pharmaceuticals LP.

Lung cancer is a leading cause of cancer death worldwide. The American Cancer Society estimates that there will be…
More »
Current Issues
View the Current Issue
HemOnc Today